Vittone, F., Chait, A., Morse, J. S., Fish, B., Brown, B. G., & Zhao, X. (2007). Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS).
Citación estilo ChicagoVittone, Francesca, Alan Chait, Josh S. Morse, Brian Fish, B. Greg Brown, and Xue-Qiao Zhao. Niacin Plus Simvastatin Reduces Coronary Stenosis Progression Among Patients With Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). 2007.
Cita MLAVittone, Francesca, et al. Niacin Plus Simvastatin Reduces Coronary Stenosis Progression Among Patients With Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). 2007.